Bliss GVS Pharma informs about Financial Results

31 Oct 2014 Evaluate

Bliss GVS Pharma has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014.

The above information is a part of company’s filings submitted to BSE

Bliss GVS Pharma Share Price

131.50 2.50 (1.94%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.